Skip to Content

M D18 (Methylphenidate Hydrochloride Extended-Release 18 mg)

Pill with imprint M D18 is Yellow, Round and has been identified as Methylphenidate Hydrochloride Extended-Release 18 mg. It is supplied by Mylan Pharmaceuticals Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 18 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for M D18

Methylphenidate hydrochloride extended-release 18 mg M D18

Methylphenidate Hydrochloride Extended-Release

Imprint
M D18
Strength
18 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Cns stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-8155
Inactive Ingredients
butylated hydroxytoluene, cellulose acetate, silicon dioxide, FD&C Blue No. 1, sodium chloride, sodium stearyl fumarate, magnesium silicate, titanium dioxide, ferric oxide yellow, soya lecithin, propylene glycol, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M D18"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.